John E Bishop
CIK 1308911 · See Remarks · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.92M
Companies
4
Total Filings
132
Lifetime Open-Market Net
-$6.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | See Remarks | 336,845 | $5.69 | $1.92M | -$33.0K | 3 | 2026-05-22 |
| LYRA | Chief Technology Officer | — | $0.70 | — | $0 | 2 | 2024-02-01 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | SVP, Chief Technology Officer | 0 | $20.01 | $0 | $0 | 3 | 2022-10-14 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Senior VP, Pharmaceutical Scie | 157,640 | — | — | -$6.40M | 124 | 2016-05-23 |
Recent Filings · Page 14 of 14
132 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-12-18 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | +13,500 | -$10.8K | EDGAR |
| 2007-03-22 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 131–132 of 132
Prev
Page 14 of 14
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.